Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines

/Passle/MediaLibrary/Images/2026-01-19-05-44-49-277-696dc4d1340f66ce3b2649b1.jpg)
/Passle/MediaLibrary/Images/2025-03-24-11-32-25-530-67e142c93014916436420e74.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-11-26-17-35-45-189-69273a7174601ea67c69fe4a.jpg)
/Passle/MediaLibrary/Images/2025-11-19-14-11-38-979-691dd01ad614ada1401cd306.jpg)